复星可以改善绝经后妇女的认知功能和生活质量
Viktoriia Myhal1, Yurii Kazakov1, Svitlana Shut1
1Poltava State Medical University , Poltava , Ukraine.
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego
|February 26, 2026
概括
转白醇补充剂显著改善了绝经后妇女的认知功能和生活质量. 这种天然化合物可能有助于减缓与年龄相关的认知衰退.
科学领域:
- 营养神经科学 营养神经科学
- 老年学是一门学科.
- 妇女健康 妇女健康
背景情况:
- 更年期与认知变化和生活质量下降有关.
- 转白醇是一种多,已证明具有抗氧化和抗炎性质.
- 研究转白醇对绝经后妇女认知功能的影响至关重要.
研究的目的:
- 评估转白醇对绝经后妇女认知功能的影响.
- 评估转白对这一人口群体生活质量的影响.
主要方法:
- 一项前性受控临床研究,涉及88名绝经后妇女.
- 随机划分为接受白醇的研究组 (n=55) 和对比组 (n=33).
- 对所有参与者进行了实验室和心理检查.
主要成果:
- 复星的摄入增加了血清的水平.
- 在白醇组 (P<0.001) 观察到认知功能 (MoCA评分) 的显著改善.
- 在这两组中,生活质量都有所改善,而在白醇组 (EQ-5D-3L尺度) 中,这一优势更大.
结论:
- 转白醇对绝经后妇女的认知功能和生活质量产生积极影响.
- 复星补充剂导致MoCA得分增加,并改善了EQ-5D-3L和MENQOL的结果.
- 复星显示出减轻绝经后妇女与年龄相关的认知衰退的潜力.
相关概念视频
Cognitive Development During Adulthood
988
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
988
Menopause
5.1K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
5.1K
Alzheimer's Disease: Treatment
1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
Pharmacodynamics in Geriatric Patients: Effects of Age
284
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
284
Atherosclerosis III: Management
516
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
516
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
735
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
735


